Herpes zoster (shingles) immunisation programme 2014 to 2015: evaluation report
Evaluation of the second year of the shingles vaccination programme in England from 2014 to 2015.
Documents
Details
The shingles vaccination programme aims to reduce the incidence and severity of shingles in those targeted by the programme by boosting individuals’ pre-existing varicella zoster virus immunity.
This report highlights the successful continuation of the shingles vaccine programme in England.
In the second year of the programme (2014 to 2015), the vaccine was offered to adults:
- aged 70 years on 1 September 2014 (born between 2 September 1943 and 1 September 1944)
- aged 78 years on 1 September 2014 (born between 2 September 1935 and 1 September 1936)
- aged 79 on 1 September 2014 (born between 2 September 1934 and 1 September 1935)
Updates to this page
Published 27 November 2015Last updated 4 December 2015 + show all updates
-
Data amendment to clinical commissioning group (CCG) and local authority (LA) future cohort data.
-
Added excel tables on shingles vaccine coverage in England by age cohort, CCG and Local Authority: 1 September 2013 to 31 August 2015.
-
First published.